Sunako Chemo Industries Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 28-12-2024
- Paid Up Capital ₹ 0.99 M
as on 28-12-2024
- Company Age 44 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Revenue 374.23%
(FY 2020)
- Profit 60.64%
(FY 2020)
- Ebitda 176.56%
(FY 2020)
- Net Worth -1.62%
(FY 2020)
- Total Assets -2.85%
(FY 2020)
About Sunako Chemo Industries
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.99 M, as per Ministry of Corporate Affairs (MCA) records.
Suresh Kolhapure, Suman Kolhapure, and Soniya Kolhapure serve as directors at the Company.
- CIN/LLPIN
U70100MH1980PTC023495
- Company No.
023495
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Nov 1980
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Pune, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Sunako Chemo Industries?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Suresh Kolhapure  | Director | 28-Nov-1980 | Current |
| Suman Kolhapure | Director | 28-Nov-1980 | Current |
| Soniya Kolhapure | Director | 07-Nov-2006 | Current |
Financial Performance of Sunako Chemo Industries.
Sunako Chemo Industries Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 374.23% increase. The company also saw a substantial improvement in profitability, with a 60.64% increase in profit. The company's net worth dipped by a decrease of 1.62%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sunako Chemo Industries?
In 2017, Sunako Chemo Industries had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Satyam Erectors Pvt LtdActive 35 years 7 monthsSuresh Kolhapure, Suman Kolhapure and 1 more are mutual person
- Sunako Constructions Pvt LtdActive 35 years 7 months
Suresh Kolhapure, Suman Kolhapure and 1 more are mutual person
- Sunako Trading And Investments Private LimitedActive 15 years 7 months
Suresh Kolhapure, Suman Kolhapure and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Sunako Chemo Industries?
Unlock and access historical data on people associated with Sunako Chemo Industries, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sunako Chemo Industries, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sunako Chemo Industries's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
